The maintenance of protein homeostasis as a response to changing external conditions is crucial for cellular survival and proper function. Since plants cannot adapt by changing location, their need for a rapid intracellular response is accentuated. The AAA ATPase CDC48 maintains protein homeostasis in conjunction with NPL4 and UFD1 by coupling ATP hydrolysis with mechanical force to extract and unfold ubiquitylated proteins from organelle membranes, chromatin, or protein complexes. Our bioinformatic analysis revealed considerable domain and binding motif differences in A. thaliana NPL4 compared to its orthologs in animals and fungi. Using ITC, MST, and SEC-MALS, we found that NPL4 and UFD1 did not heterodimerize, NPL4 bound to CDC48A in the absence of UFD1, and the complex was not stable in vitro. Additionally, we provided the first medium-high-resolution reconstructions of CDC48A in both an AMP-PNP bound and apo state, using cryo-EM. AMP-PNP bound CDC48A was reconstructed in both a tense (3.3 Å) and relaxed (3.5 Å) conformation with the N domain was positioned above or coplanar with the D1 ring, respectively. Our heterogeneity analysis using CryoDRGN revealed continuous flexibility of the N domains between the two conformations. The apo state was reconstructed as a single conformation at 4.4 Å resolution. A cryo-EM reconstruction of the complex was also obtained at a resolution of ~6 Å, which showed expected cofactor stoichiometry and binding positions. Through our efforts, we have observed differences in the interaction between A. thaliana CDC48A and its cofactors UFD1 and NPL4 that may correspond to functional differences between kingdoms.

京都大学 / 0048 / 新制・課程博士 / 博士(理学) / 甲第22293号 / 理博第4607号 / 新制||理||1661(附属図書館) / 京都大学大学院理学研究科生物科学専攻 / (主査)准教授 細川 暢子, 教授 森 和俊, 教授 杤尾 豪人 / 学位規則第4条第1項該当 / Doctor of Science / Kyoto University / DGAM

Indiana University-Purdue University Indianapolis (IUPUI) / Heat Shock Protein 60/10 (HSP60/10, or GroEL/ES in bacteria) chaperonin systems play a critical role in protein homeostasis through facilitating proper folding of misfolded or partially folded polypeptides that are otherwise prone to aggregation. HSP60 chaperonins are highly conserved and essential in nearly all organisms studied thus far, making them a promising target for antibiotic development. Early high-throughput screens in the Johnson lab have identified five main scaffolds that, though hit-to-lead development, have been optimized for chaperonin inhibition and antimicrobial effects. While these initial studies have shown promising evidence to support the viability of a chaperonin-targeting antibiotic strategy, it was unclear whether the conservation of human HSP60 (48% identity to bacterial GroEL) would hinder this therapeutic strategy from advancing due to potential toxicity associated with off-target inhibition of the human homolog. Additionally, while chaperonin inhibition often correlated with cytotoxicity to the various pathogens studied, there was a clear need to investigate inhibitor mechanisms to 1) verify on-target effects, and 2) guide future development of more potent and selective chaperonin-targeting antibiotic candidates. Herein, we conduct a medium-throughput screening of known bioactive molecules, approved drugs, and natural products against both bacterial GroEL and human HSP60, demonstrating that most molecules exhibited low-to-no toxicity to human cells in culture, despite being near equipotent inhibitors of human HSP60 and E. coli GroEL in our refolding assays. Thus, sequence conservation between human HSP60 and bacterial GroELs does not necessarily predict toxicity in vivo. We then investigate inhibitory mechanisms of our most well-established inhibitor series, the phenylbenzoxazole (PBZ) series, identifying three binding sites whereby PBZ molecules modulate GroEL folding and ATPase functions in a site-specific manner, predominately through its ability to interact with its co-chaperone GroES. Finally, we demonstrate that two standard of care drugs for T. brucei infections, suramin and nifurtimox, may elicit their trypanocidal effects through inhibiting HSP60. Due to structural similarities, we then screened our N-acylhydrazone (NAH) and α,β-unsaturated ketone (ABK) series of HSP60 inhibitors against T. brucei, finding that they are highly potent and selective trypanocidal agents. Together, these studies further support HSP60 as a viable drug target for antibiotic development. / 2025-07-03

Every cell consists of carefully orchestrated biomolecules such as lipids, carbohydrates, and proteins. To maintain internal stability (homeostasis), cells maintain the right amount of these molecules at the right time and at the right place. This process is especially true for proteins since they are the foundation functional units within the cell. Proteins form structures and perform chemistry that bestows cells overarching functional roles. Cells maintain protein homeostasis (proteostasis) by modulating synthesis, folding, and degradation processes (turnover) to maintain the abundance levels for all proteins. This is the foundational kinetic model of proteostasis that is covered in this work, and it comprises protein abundance and turnover essential for protein homeostasis. When proteostasis is lost, cells may also fail to perform their internal cellular functions which will impact their external role. The sustained loss of proteostasis leads to disease. In the area of proteomics, we seek out the mechanisms of proteome change that result in the loss of normal proteostasis that are associated with disease states. As biochemists we explore the role of different proteins within biological systems and disease states. Predominantly, these studies involve isolating proteins (generally one at time) to measure abundance levels, function, and structure. In more recent years, technological advances in liquid chromatography and mass spectrometry (LC-MS) ushered in the golden age of proteomics. With LC-MS we can explore thousands of proteins in a single experiment to measure their expression levels. This work covers the fundamentals of this process as well as examples of LC-MS based proteomics for biomarker discovery and individual protein dynamics. In a sense, these experiments are like taking a snapshot of what proteins are found within a biological system at a given moment. However, cells are not static systems, rather they are dynamic systems in which proteins are being created and destroyed to maintain proteostasis. In this regard, LC-MS has recently become a powerful tool to explore protein turnover for thousands of proteins. Combined with protein abundance measurements, protein turnover yields a dynamic image of the internal state of the cell. This work applies the ideas within the kinetic model of proteostasis to explore the changes in protein homeostasis associated with Apolipoprotein E (ApoE) isoforms. ApoE isoforms are a genetic risk factor of ongoing research because of their role in disease and longevity. This work reviews some of the proposed mechanisms associated with ApoE genotype, and the LC-MS experiment we created to measure both proteome wide abundance and turnover changes associated with ApoE genotype. Our findings not only provide evidence that unifies previous ApoE studies, and it provides a benchmark for how to incorporate both quantitative and kinetic proteomics to monitor proteostasis.

Die erfolgreiche Synthese und Faltung von Proteinen ist eine Voraussetzung der Zellfunktion und ein Versagen der Proteinhomöostase führt zu Krankheit oder Tod. In der Zelle sichern molekulare Chaperone die korrekte Faltung der Proteine oder tragen zur Entsorgung unwiederbringlich fehlgefalteter Proteinsubstrate bei. Unter diesen Chaperonen sind kleine Hitzeschockproteine (sHsp) ein ATP-unabhängiger Teil des Proteostasenetzwerks. In dieser Arbeit habe ich das bisher wenig erforschte sHsp HSP-17 aus C. elegans untersucht. Im Gegensatz zu anderen sHsps zeigte HSP-17 nur eine geringe Aktivität beim Verhindern der Aggregation von Proteinsubstraten. Stattdessen konnte ich in vitro zeigen, dass HSP-17 die Aggregation von Modellsubstraten fördert, was hier für Metazoen-sHsps erstmals gezeigt wurde. HSP-17 kopräzipitiert mit Substraten und modifiziert deren Aggregate möglicherweise. HSP-17 kolokalisiert in vivo mit Aggregaten, und seine aggregationsfördernde Aktivität konnte ich für das physiologische Substrat KIN-19 und heterolog exprimierte polyQ-Peptide validieren. Durch ex vivo Analysen konnte ich zeigen, dass die Aktivität von HSP-17 für die Fitness relevant ist  In einem zweiten Projekt habe ich zur Entwicklung eines neuen Modelles für Aß-Pathologie in C. elegans beigetragen, welches substöchiometrische Markierungen verwendet, um eine zeitnahe Visualisierung der Aß-Aggregation in spezifischen Zelltypen zu ermöglichen. Das Modell spiegelt bekannte Phänotypen der Aß-Proteotoxizität aus Menschen und bestehenden C. elegans Aß-Stämmen wider. Interessanterweise zeigt eine Untergruppe der Neuronen, die IL2-Neuronen, eine höhere Anfälligkeit für die Aggregation und Proteotoxizität von Aß1-42. Eine gezielte Reduktion von Aß1-42 in IL2 Neuronen führt zu einer systemischen Reduktion der Pathologie. Somit bietet das Modell eine neue Plattform, um die Bedeutung molekularer Chaperone, wie z. B. der sHsps, für Amyloidosen zu untersuchen, auch im Hinblick auf menschliche Erkrankungen. / Successful synthesis and folding of proteins is a prerequisite for cellular function and failure of protein homeostasis leads to disease or death. Within the cell, molecular chaperones ensure correct protein folding or aid in the disposal of terminally misfolded protein substrates. Among these chaperones, small heat shock proteins (sHsps) are ATP-independent members of the proteostasis network. In this work, I analyzed the so far under-researched C. elegans sHsp HSP-17. Unlike other sHsps, HSP-17 exhibited only weak activity in preventing aggregation of protein substrates. Instead, I could show in vitro that HSP-17 can promote the aggregation of protein substrates, which is the first demonstration for metazoan sHsps. HSP-17 co-precipitates with substrates and potentially modifies the aggregates.  HSP-17 colocalizes with aggregates and pro-aggregation activity is present in vivo, which I demonstrated for the physiological substrate KIN-19 and heterologously expressed amyloidogenic polyQ peptides. By physiological, biochemical and proteomic analysis I showed that HSP-17 activity is relevant for organismal fitness In a second project, I contributed to the development and characterization of a novel model of Aß pathology in C. elegans. This new AD model employs sub-stoichiometric labeling to allow live visualization of Aß aggregation in distinct cell types. The model mirrors known phenotypes of Aß proteotoxicity in humans and existing C. elegans Aß strains. Interestingly, a subset of neurons, the IL2 neurons, is shown to be more vulnerable to Aß proteotoxicity and targeted depletion of Aß in these neurons systemically ameliorates pathology. Thereby, the model presents a new platform to assess the relevance of molecular chaperones such as sHsps in amyloidosis with a perspective on human disease.

Proteins are the center of all biochemical reactions in living organisms. Proteins need to be present at the right time, in the right place, with the correct concentration and have the right shape to carry their designated function. Protein homeostasis is when all proteins in the proteome are in functional balance, and such balance is maintained by synthesis, folding, and degradation machinery. When protein homeostasis is lost, organisms start to age and develop diseases. To truly unveil disease mechanisms and provide more efficient means for treatment and prevention, we need a holistic understanding of the mechanism of protein homeostasis. Currently, most biomarker studies focus on the quantity aspect of the proteome. The quality aspect has been neglected because of the difficulties in measuring quality in vivo with cellular context retained. This work first proposes a kinetic model of protein homeostasis, which can provide a holistic view, including both quantity and quality aspects, as well as monitor the complex protein interactions. Using mass spectrometry, the model quantifies the quality of proteome by linking the concentration of protein, mRNA, and the rate protein synthesis, folding, unfolding, misfolding, refolding, degradation of the correctly folded protein, and degradation of protein aggregation. We then applied the ideas within the kinetic model of protein homeostasis to study several proteins in human blood serum. We reviewed the current known mechanism of transthyretin mediated amyloidosis and proposed a study approach that can measure the quality difference between different transthyretin's mutation stages, as well as monitor if the transthyretin amyloidosis has been developed at the early stage. We also used mass-spectrometry to quantify the surface accessibility differences in human serum albumin (HSA) between patients with and without rheumatoid arthritis (RA). We found certain residues are less reactive in the RA group, indicating a structural change in HSA. Such structural changes, possibly caused by ligand binding, stabilized HSA and explained the heat denature curve shift we observed. In the end, we introduced a novel assay, Iodination Protein Stability Assay (IPSA). IPSA is used to quantify protein quality by measuring protein folding stability. We applied IPSA to human serum, and it is the first in situ study, to our best knowledge, that measure the protein folding stability of proteins from human serum. We confirmed that IPSA is sensitive to measuring the differences in protein folding stability between transferrin's different iron-binding states. Together, this dissertation conveys the importance of adding quality aspects to current quantity-focused research in curing diseases and improving the quality of human life.